Olopatadine Hydrochloride
16 NDCs across 10 manufacturers|13 Generic,3 Brand
Olopatadine Hydrochloride is used to treat allergic conjunctivitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 18, 1996, and the first generic was approved Oct 8, 2014. FDA's Orange Book lists 3 AB-rated (therapeutically equivalent) products for this ingredient.
Olopatadine Hydrochloride is available as 16 NDCs from 10 manufacturers (13 generic, 3 brand), with NADAC prices from $1.27 to $6.20 per ML — the most expensive product costs about 4.9× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
16
13G / 3B
Manufacturers
10
competing in market
Price Spread
$1.27 – $6.20
per ML, 13 of 16 NDCs
7d Activity
avg -1.1% WoW · of 16 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Alcon Laboratories, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Histamine-1 Receptor Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
10 manufacturers producing OLOPATADINE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PATADAY ONCE DAILY 0.7% DROPS | $6.2023 per ML | — |
PATADAY ONCE DAILY 0.2% DROPS | $5.8929 per ML | — |
OLOPATADINE HCL 0.2% EYE DROP | $4.2477 per ML | — |
OLOPATADINE HCL 0.1% EYE DROPS | $3.0649 per ML | — |
OLOPATADINE HCL 0.2% EYE DROP | $2.9636 per ML | -1.11% |
GNP OLOPATADINE 0.2% EYE DROP | $2.9636 per ML | -1.11% |
OLOPATADINE HCL 0.2% EYE DROP | $2.9636 per ML | -1.11% |
OLOPATADINE HCL 0.2% EYE DROP | $2.9636 per ML | -1.11% |
OLOPATADINE HCL 0.2% EYE DROP | $2.9636 per ML | -1.11% |
PATADAY TWICE DAILY 0.1% DROPS | $2.4820 per ML | — |
OLOPATADINE HCL 0.2% EYE DROP | $1.9835 per ML | -1.06% |
GNP OLOPATADINE 0.1% EYE DROPS | $1.2737 per ML | +0.47% |
OLOPATADINE HCL 0.1% EYE DROP | $1.2737 per ML | +0.47% |
OLOPATADINE 665 MCG NASAL SPRY | $0.8495 per GM | -2.11% |
OLOPATADINE 665 MCG NASAL SPRY | $0.8495 per GM | -2.11% |
OLOPATADINE 665 MCG NASAL SPRY | $0.8495 per GM | -2.11% |
Frequently Asked Questions
What is Olopatadine Hydrochloride used to treat?
Olopatadine Hydrochloride is used to treat allergic conjunctivitis, per the National Library of Medicine's MED-RT classification.
When did Olopatadine Hydrochloride become available as a generic?
FDA approved the first generic Olopatadine Hydrochloride (ANDA) on Oct 8, 2014. The Orange Book currently lists 3 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Olopatadine Hydrochloride products are on the market?
The Olopatadine Hydrochloride drug market contains 16 NDCs from 10 manufacturers — 13 generic and 3 brand products.
What is the price range for Olopatadine Hydrochloride?
NADAC reference prices for Olopatadine Hydrochloride range from $1.2737 to $6.2023 per ML — the most expensive product costs about 4.9× the cheapest. 3 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Olopatadine Hydrochloride cheaper than brand?
The average generic NADAC for Olopatadine Hydrochloride is $2.6662 per ML, versus $4.8590 for brand-labeled products — generic is about 45% cheaper on average.
Which manufacturers make Olopatadine Hydrochloride?
10 manufacturers list Olopatadine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Alcon Laboratories, Inc. (3), Alembic Pharmaceuticals Inc. (2), BluePoint Laboratories (2), AmerisourceBergen (2), Rising Pharma Holdings Inc. (2).
How has the price of Olopatadine Hydrochloride changed recently?
Over the past 7 days, 6 Olopatadine Hydrochloride NDCs rose and 27 fell, with a market-wide average change of -1.1%.